SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-005291
Filing Date
2022-04-11
Accepted
2022-04-11 17:19:33
Documents
70
Period of Report
2022-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q cydy-20220228x10q.htm   iXBRL 10-Q 2357020
2 EX-3.1 cydy-20220228xex3d1.htm EX-3.1 273483
3 EX-10.1 cydy-20220228xex10d1.htm EX-10.1 71927
4 EX-10.2 cydy-20220228xex10d2.htm EX-10.2 48507
5 EX-31.1 cydy-20220228xex31d1.htm EX-31.1 9468
6 EX-32.1 cydy-20220228xex32d1.htm EX-32.1 5617
7 GRAPHIC cydy-20220228xex3d1001.jpg GRAPHIC 3705
  Complete submission text file 0001558370-22-005291.txt   8755778

Data Files

Seq Description Document Type Size
8 EX-101.SCH cydy-20220228.xsd EX-101.SCH 69286
9 EX-101.CAL cydy-20220228_cal.xml EX-101.CAL 59039
10 EX-101.DEF cydy-20220228_def.xml EX-101.DEF 269956
11 EX-101.LAB cydy-20220228_lab.xml EX-101.LAB 443120
12 EX-101.PRE cydy-20220228_pre.xml EX-101.PRE 417578
64 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20220228x10q_htm.xml XML 1201893
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 22820432
SIC: 2834 Pharmaceutical Preparations